- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04952701
Evaluating the Success of Habitual Multifocal Wearers When Refit With a New Lens Design
April 25, 2022 updated by: CooperVision, Inc.
The objective of the study was to adapt existing multifocal soft lens wearers to a CONTROL lens for 2 weeks and then evaluate the success of switching them to the TEST lens, with a review after 2 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This was a prospective, crossover, bilateral daily wear, and subject masked dispensing study.
The habitual contact lenses were not optimized.
There was no randomization of the study lenses, participants wore the control lenses for the first wear period and the test for the second wear period.
Participants wore each study lens for 3-7 days and then attend a prescription optimization visit.
After this optimization visit, they wore each study lens for a 2-week period.
During the 2-week wear period, participants recorded their subjective lens-wear experience remotely.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Ocoee, Florida, United States, 34761
- Coan Eyecare
-
-
Kansas
-
Pittsburg, Kansas, United States, 66762
- Kannarr Eye Care
-
-
New York
-
Vestal, New York, United States, 13850
- Sacco Eye Group PLLC
-
-
Ohio
-
Granville, Ohio, United States, 43023
- ProCare Vision Center
-
-
Pennsylvania
-
College, Pennsylvania, United States, 16801
- Nittany Eye Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
42 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 42 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Self reports having a full eye examination in the previous two years;
- Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Habitually wears multifocal soft contact lenses, for the past 3 months minimum;
- Has refractive astigmatism no higher than -0.75DC;
Is presbyopic and requires a reading addition of at least +0.75D and no more than
+2.50D;
- Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS)
Exclusion Criteria:
- Is participating in any concurrent clinical or research study;
- Has any known active* ocular disease and/or infection that contraindicates contact lens wear;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
- Has known sensitivity to the diagnostic sodium fluorescein used in the study;
- Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
- Has undergone refractive error surgery or intraocular surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Lens
All subjects will wear control lenses for two weeks and then will wear Test lenses for two weeks.
|
Control Multifocal lenses
Test Multifocal lenses
|
|
Experimental: Test Lens
After wearing control lenses for two weeks, all subjects will wear test lenses for two weeks.
|
Control Multifocal lenses
Test Multifocal lenses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort on Insertion
Time Frame: Day 1 after Lens Dispense Visit
|
Subjective ratings of comfort on insertion using a 0-10 scale, in 0.5 steps (0=- painful, 10- Can't feel the lenses).
|
Day 1 after Lens Dispense Visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lyndon Jones, University of Waterloo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2021
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
January 14, 2022
Study Registration Dates
First Submitted
June 28, 2021
First Submitted That Met QC Criteria
June 28, 2021
First Posted (Actual)
July 7, 2021
Study Record Updates
Last Update Posted (Actual)
April 27, 2022
Last Update Submitted That Met QC Criteria
April 25, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-119
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on Control lenses
-
Essilor InternationalActive, not recruitingMyopia | Myopia, ProgressiveSingapore
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityGuangzhou Youyan Vision Technology Co., Ltd.Not yet recruiting
-
Aller, Thomas A., ODJohnson & Johnson Vision Care, Inc.CompletedMyopia | Esophoria | Fixation Disparity
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Essilor InternationalActive, not recruiting